HAMBURG, Germany & MADISON, Wis.--(BUSINESS WIRE)--Biotech and pharma labs performing endpoint polymerase chain reaction (PCR) can amplify samples in as little as 15 minutes with new Promega GoTaq® ...
Molecular analysis using PCR techniques demands both precision and versatility, integrating methods that offer unique yet complementary strengths. However, researchers can face challenges balancing ...
DUBLIN--(BUSINESS WIRE)--The "Polymerase Chain Reaction (PCR) Technologies and Global Markets 2023-2028" report has been added to ResearchAndMarkets.com's offering. PCR is a powerful molecular biology ...
To permanently access this Infographic for free, fill out the short form below. There are many different polymerase chain reaction (PCR) workflows, including end-point PCR, qualitative PCR (qPCR), and ...
Pathologic complete response (pCR) is not a reliable surrogate endpoint in trials evaluating neoadjuvant therapies for early breast cancer, according to a critical analysis of the literature. This ...
You're ready to amplify some DNA - we're ready to help you get it done! If you like these videos, check out our Student Resource Center for more helpful articles and ...
A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost with an 'auto-pilot' mindset. However, how many secrets are hidden ...
In this review, we provide a concise overview of neoadjuvant systemic therapy in early-stage HER2-positive breast cancer, with a focus on various chemotherapy backbones and de-escalation strategies.
In collaboration with San Diego-based Althea Technologies, Beckman Coulter http://www.beckmancoulter.com recently released the GenomeLab GeXP Genetic Analysis System ...
Patients with resectable non–small cell lung cancer (NSCLC) often receive treatment before they undergo surgery. For such patients who achieve a pathologic complete response (pCR), the chances of ...
Credit: Getty Images. The pembrolizumab regimen statistically significantly improved pCR rate. Pembrolizumab in combination with chemotherapy led to a statistically significant improvement in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback